Athens

Athens is rapidly emerging as a premier life sciences hub in Southeast Europe, uniquely blending a rich legacy of medical tradition with cutting-edge healthcare innovation.

The city is best known for its robust pharmaceutical industry, where local leaders like ELPEN and Demo S.A. drive significant drug development and high-volume generic manufacturing for global markets.

Athens’s growing biotechnology sector is anchored by the new Athens LifeTech Park, which fosters translational research and accelerates early-stage biotech startups through state-of-the-art preclinical research services.

The ecosystem is further bolstered by world-class academic research from the National and Kapodistrian University of Athens, producing a steady pipeline of STEM talent and breakthrough discoveries in molecular biology and genomics.

In the medical device and digital health space, the city is a hotspot for eHealth solutions and AI-driven diagnostics, supported by innovation clusters like Science Agora.

With a strong focus on clinical trials and biomanufacturing resilience, Athens offers a competitive, high-growth environment for international investors.

This Mediterranean gateway effectively connects European regulatory standards with emerging markets, making it a strategic destination for life sciences investment.

Through strategic collaborations between the public healthcare sector and private R&D, Athens is redefining itself as a center for precision medicine and global health excellence.